Researcher
Benedicte De Winter
- Research Expertise:- Visceral pain - Inflammation - ileus - irritable bowel syndrome - IBS - inflammatory bowel disease - IBD - sepsis - experimental and clinical translational research - medisch vaardighedenonderwijs
- Keywords:VISCERAL PAIN, SEPSIS, IRRITABLE BOWEL SYNDROME, INFLAMMATION, INFLAMMATORY BOWEL DISEASE, Medicine
- Disciplines:Gastro-enterology, Inflammation, Pathophysiology
- Research techniques:- in vivo animal models of IBS, IBD and sepsis - visceromotor response and afferent neuronal activity - motility and sensitivity assays - inflammation measurements - Elisa, flowcytometry - vaardigheden, portfolio, stationsproeven
- Users of research expertise:- research labs - pharmaceutical industry - (bio-, para-) medical schools
Affiliations
- Laboratory Experimental Medicine and Pediatrics (LEMP) (Research group)
Responsible
From1 Oct 2013 → Today - Laboratory Experimental Medicine and Pediatrics (LEMP) (Research group)
Member
From1 Oct 2003 → 30 Sep 2013 - Primary and interdisciplinary care Antwerp (ELIZA) (Research group)
Member
From1 Oct 2003 → 30 Sep 2008
Projects
1 - 10 of 32
- Automation of a mucin mRNA isoform-based biomarker platform to monitor patients with inflammatory bowel diseases.From1 Apr 2024 → TodayFunding: IOF - technology validation in lab
- Crosstalk between MUC13 signalling and the mucosal microbiota in gastric cancer development.From1 Jan 2024 → TodayFunding: Nonprofit institution or equivalents
- REspiratory Virus Repository ANTwerp (ReViRAnt).From1 Jan 2023 → TodayFunding: Flemish Resilience. Government of Flanders Recovery Plan - strengthening R&D
- Turning the understanding of inflammation-related pathology into new biomarkers and treatments using next-generation technologies and high-throughput data mining.From1 Nov 2022 → TodayFunding: BOF - postdoctoral mandates
- A mucin mRNA isoform-based biomarker assay to improve treatment response in patients with inflammatory bowel diseases.From1 Sep 2022 → 31 Aug 2023Funding: IOF - technology validation in lab
- High-end comprehensive GCxGC-QTOF-MS research facility for volatile and semivolatile compounds (GALILEO).From1 Jun 2022 → TodayFunding: FWO Medium Size Research Infrastructure
- Assessing health effects of air pollution by non-invasive exhaled breath analysis (ALERT).From1 Jun 2021 → 31 May 2023Funding: Provinces
- Mucin isoform-microbiome crosstalk shaping the course of COVID-19: a help in patient stratification?From1 Nov 2020 → 31 Oct 2021Funding: FWO Special Call for Covid-19 research projects, BOF - projects
- Study of the mechanisms involved in MUC1/MUC13-induced intestinal barrier disruption during inflammatory bowel diseases: a translational approach.From1 Nov 2020 → TodayFunding: FWO junior postdoctoral fellowship
- Functional characterization of human mast cells and basophils in the pathophysiology of diarrhea-predominant irritable bowel syndrome.From1 Oct 2020 → 30 Sep 2022Funding: FWO fellowships
Publications
31 - 40 of 165
- Profiling of proteases as potential therapeutic targets(2022)
Authors: Michelle De bruyn, Ingrid De Meester, Benedicte De Winter
Number of pages: 259 - SARS-CoV-2 mRNA vaccination is not associated with the induction of anti-HLA or non-HLA antibodies(2022)
Authors: Sonja Verheyden, Barbara Depreter, Christine Heylen, Elke Coeman, Steven Abrams, Benedicte De Winter, Annick Massart, Lissa Pipeleers, Frans Claas, Kevin Ariën, et al.
Pages: 1 - 7 - Effect of resolvins on sensitisation of TRPV1 and visceral hypersensitivity in IBS(2021)
Authors: Eluisa Perna, Javier Aguilera-Lizarraga, Morgane V. Florens, Piyush Jain, Stavroula A. Theofanous, Nikita Hanning, Joris De Man, Maya Berg, Benedicte De Winter, Yeranddy Aguiar Alpizar, et al.
Pages: 1275 - 1286 - The next generation(2021)
Authors: Kristien Ledeganck, Marieke den Brinker, Emma Peeters, Aline Verschueren, Benedicte De Winter, Annick France, Hilde Dotremont
- Body composition monitoring in children and adolescents(2021)
Authors: Annelies Van Eyck, Sofie Eerens, Eline Lauwers, Benedicte De Winter, Johanna H. van der Lee, Koenraad Van Hoeck, Kristien Ledeganck
Pages: 1 - 12 - Developing experimental therapeutic strategies for impaired gastrointestinal permeability, bacterial translocation, intestinal inflammation, and adhesiogenesis during sepsis(2021)
Authors: Philip Plaeke, Benedicte De Winter, Guy Hubens, Philippe Jorens, Joris De Man
Number of pages: 291 - Improving self-reflection assessment practices(2021)
Authors: Liesje Coertjens, Marije Lesterhuis, Benedicte De Winter, Maarten Goossens, Sven De Maeyer, Nele Michels
Pages: 525 - 535 - Review, performance comparison, and validation of models predicting type 2 diabetes remission after bariatric surgery in a Western European population(2021)
Authors: Philip Plaeke, Anthony Beunis, Martin Ruppert, Joris De Man, Benedicte De Winter, Guy Hubens
Pages: 1549 - 1560 - The effect of weight regain on cardiometabolic health in children with obesity(2021)
Authors: Eline Vermeiren, Luc Bruyndonckx, Benedicte De Winter, Stijn Verhulst
Pages: 2575 - 2586 - Improving treatment outcome in children with obesity by an online self-control training(2021)
Authors: Eline Vermeiren, Tiffany Naets, Leentje Vervoort, Marijke Ysebaert, Nele Baeck, Ann De Guchtenaere, Maria Van Helvoirt, Ann Tanghe, Luc Bruyndonckx, Benedicte De Winter, et al.
Patents
1 - 9 of 9
- Method for determining the severity and prognosis of rsv infection (Inventor)
- Mucins and isoforms thereof in diseases characterized by barrier dysfunction (Inventor)
- Mucin isoforms in diseases characterized by barrier dysfunction (Inventor)
- Mucins and isoforms thereof in diseases characterized by barrier dysfunction (Inventor)
- Method for determining the severity and prognosis of RSV infection (Inventor)
- Bis(acetamidophenyl) guanidinophenyethylphosphonates for use in the prevention and/or treatment of PAR-related diseases. (Inventor)
- Mucin isoforms in diseases characterized by barrier dysfunction (Inventor)
- Bis(acetamidophenyl) guanidinophenylethylphosphonates for use in the prevention and/or treatment of par-related diseases (Inventor)
- Bis(acetamidophenyl) guanidinophenylethylphosphonates for use in the prevention and/or treatment of par-related diseases (Inventor)
Linked dataset
1 - 1 of 1